Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.28
0.08 (7.11%)
At close: Aug 18, 2025, 3:59 PM
1.27
-0.78%
Pre-market: Aug 19, 2025, 04:00 AM EDT
7.11% (1D)
| Bid | 1.24 |
| Market Cap | 292.3M |
| Revenue (ttm) | 9.56M |
| Net Income (ttm) | -16.21M |
| EPS (ttm) | -0.17 |
| PE Ratio (ttm) | -7.53 |
| Forward PE | -19.7 |
| Analyst | Buy |
| Ask | 1.31 |
| Volume | 1,913,526 |
| Avg. Volume (20D) | 2,511,353 |
| Open | 1.24 |
| Previous Close | 1.20 |
| Day's Range | 1.19 - 1.28 |
| 52-Week Range | 0.37 - 1.31 |
| Beta | 1.66 |
About LCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Lineage Cell Therapeutics has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Lineage Cell Therapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
-28.99%
Lineage Cell Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Takes $46,000 Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)Squarepoint Ops LLC acquired a new stake in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) during the 4th quarter, according to the company in its most recent filing with the ...
